ShareValue.ai

ShareValue scores for M3V.XETRA: Valuation 31, Quality 37, Growth 62, Health 64.

MeVis Medical Solutions AG logo

M3V.XETRA
XETRA

MeVis Medical Solutions AG

€24.20(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 11%
Valuation
31
Overvalued
Price vs Value
Quality
37
Weak
Business Strength
Growth
62
Moderate
Revenue & Earnings
Health
64
Moderate
Financial Stability
Momentum
58
Neutral
Price Trend

Company Details

About

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; as well as provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. In addition, the company provides three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians; and internet-based special applications in teleradiology. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.

Score Analysis

AI Investment Thesis

Data as of:Jul 9, 2026
|
Last calculated:Jul 9, 2026